ETRACIK 0002088082SIC 2836· Biological Products

Electra Therapeutics, Inc.

Name: Electra Therapeutics, Inc. — SEC EDGAR Filings (CIK 0002088082)
Creator: Electra Therapeutics, Inc.
License: https://www.sec.gov/foia/about-foia

2 SEC EDGAR filings indexed (CIK 0002088082) across 2 form types.

Filing profile

Electra Therapeutics, Inc. (ETRA) has 2 SEC filings indexed on SecFilingDex, across 2 form types, from September 18, 2026 to September 28, 2026. The filer is classified under Biological Products (SIC 2836).

Its most frequent disclosure is the SC 13G (5%+ passive stake) with 1 filing — Short-form disclosure of beneficial ownership above 5% by passive investors with no control intent. 2 of these filings were disclosed in the twelve months to September 28, 2026.

Disclosure mix

1SC 13G5%+ passive stake · event-driven
1424B4Final prospectus · event-driven

Profile derived from 2 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.

All filings

Authoritative source

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2088082&type=&dateb=&owner=include&count=40 ↗

SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.

Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.